Carole Devaux

Latest publications

The case for simplifying and using absolute targets for viral hepatitis elimination goals.

  • HIV Clinical and Translational Research
September 26, 2020
2020 Sep. J Viral Hepat. Online ahead of print.
By:
  • Polaris Observatory Collaborators (Devaux C. as LIH collaborator).

Combination disease prevention in prisons: a comprehensive programme in Luxembourg. In Compendium of good practices in the health sector response to viral hepatitis in the WHO European Region. (Book Chapter)

  • HIV Clinical and Translational Research
  • Clinical and Epidemiological Investigation Center
July 27, 2020
2020 Jul. Copenhagen: WHO Regional Office for Europe, 2020. p.50-53. ISBN 9289055162.
By:
  • Hoffmann P
  • Arendt V
  • Fischer A
  • Menster M
  • Etienne V
  • Meyers J
  • Conrath M
  • Stein R
  • Braunert C
  • Foulon M-L
  • Seguin-Devaux C.

HIV outbreaks among people who inject drugs in Europe, North America, and Israel.

  • HIV Clinical and Translational Research
June 01, 2020
2020 Jun. Lancet HIV.7(6):e434-e442.
By:
  • Des Jarlais DC
  • Sypsa V
  • Feelemyer J
  • Abagiu AO
  • Arendt V
  • Broz D
  • Chemtob D
  • Seguin-Devaux C
  • Duwve JM
  • Fitzgerald M
  • Goldberg DJ
  • Hatzakis A
  • Jipa RE
  • Katchman E
  • Keenan E
  • Khan I
  • Konrad S
  • McAuley A
  • Skinner S
  • Wiessing L.

A class of potent Inhibitors of the HIV-1 nucleocapsid protein based on aminopyrrolic scaffolds.

  • HIV Clinical and Translational Research
May 14, 2020
2020 May. ACS Med Chem Lett.11(5):698-705.
By:
  • Ciaco S
  • Humbert N
  • Real E
  • Boudier C
  • Francesconi O
  • Roelens S
  • Nativi C
  • Seguin-Devaux C
  • Mori M
  • Mely Y.

Drug-related infectious diseases in Europe. Update from the EMCDDA expert network, 2020. (Book)

  • HIV Clinical and Translational Research
May 01, 2020
2020 May. Luxembourg: Publications Office of the European Union, 2020. 27 p. ISBN 978-92-9497-492-1.
By:
  • EMCDDA expert network (Devaux C. as collaborator for DRID network).

Molecular epidemiology of the HIV-1 subtype B sub-epidemic in Bulgaria.

  • HIV Clinical and Translational Research
April 14, 2020
2020 Apr. Viruses.12(4):441.
By:
  • Alexiev I
  • Campbell EM
  • Knyazev S
  • Pan Y
  • Grigorova L
  • Dimitrova R
  • Partsuneva A
  • Gancheva A
  • Kostadinova A
  • Seguin-Devaux C
  • Switzer WM.

(Thia)calixarenephosphonic acids as potent inhibitors of the nucleic acid chaperone activity of the HIV-1 nucleocapsid protein with a new binding mode and multi-target antiviral activity.

  • HIV Clinical and Translational Research
April 10, 2020
2020 Apr. ACS Infect Dis.6(4):687-702. Epub 2020 Feb 21.
By:
  • Humbert N
  • Kovalenko L
  • Saladini F
  • Giannini A
  • Pires M
  • Botzanowski T
  • Cherenok S
  • Boudier C
  • Sharma KK
  • Real E
  • Zaporozhets OA
  • Cianferani S
  • Seguin-Devaux C
  • Poggialini F
  • Botta M
  • Zazzi M
  • Kalchenko VI
  • Mori M
  • Mely Y.

Less cytotoxic protoflavones as antiviral agents: Protoapigenone 1′-O-isopropyl Ether shows improved selectivity against the Epstein-Barr Virus lytic cycle.

  • HIV Clinical and Translational Research
December 04, 2019
2019 Dec. Int J Mol Sci.20(24):6269.
By:
  • Vagvolgyi M
  • Girst G
  • Kusz N
  • Otvos SB
  • Fulop F
  • Hohmann J
  • Servais JY
  • Seguin-Devaux C
  • Chang FR
  • Chen MS
  • Chang LK
  • Hunyadi A.

Combattre l’hépatite C chez les usagers de drogues injectables au Luxembourg : illustration d’une approche intersectorielle.

  • HIV Clinical and Translational Research
December 01, 2019
2019 Dec. Addiction(s) : recherches et pratiques.(4):22-25.
By:
  • Berndt N
  • Devaux C
  • Seixas R.

Predominance of the heterozygous CCR5 delta-24 deletion in African individuals resistant to HIV infection might be related to a defect in CCR5 addressing at the cell surface.

  • HIV Clinical and Translational Research
  • Platform National Cytometry Platform
  • Immuno-Pharmacology and Interactomics
September 01, 2019
2019 Sep. J Int AIDS Soc.22(9):e25384.
By:
  • Arendt V
  • Amand M
  • Iserentant G
  • Lemaire M
  • Masquelier C
  • Ndayisaba GF
  • Verhofstede C
  • Karita E
  • Allen S
  • Chevigne A
  • Schmit JC
  • Bercoff DP
  • Seguin-Devaux C.

FHR4-based immunoconjugates direct complement-dependent cytotoxicity and phagocytosis towards HER2-positive cancer cells.

  • HIV Clinical and Translational Research
  • Immuno-Pharmacology and Interactomics
  • Platform National Cytometry Platform
July 31, 2019
2019 Jul. Mol Oncol.13(12):2531-2553. Epub 2019 Sep 30.
By:
  • Seguin-Devaux C
  • Plesseria JM
  • Verschueren C
  • Masquelier C
  • Iserentant G
  • Fullana M
  • Jozsi M
  • Cohen JHM
  • Dervillez X.

EMCDDA Case study 5 — Expanding HCV screening and hepatitis treatment and care for PWID to harm reduction centres. In Hepatitis C: new models of care for drugs services. (Book Chapter)

  • HIV Clinical and Translational Research
July 01, 2019
2019 Jul. EMCDDA, 2019. p.43-49. ISBN NA.
By:
  • Devaux C
  • Arendt V.

Drug-related infectious diseases: Update from the EMCDDA expert network. (Book)

  • HIV Clinical and Translational Research
June 01, 2019
2019 Jun. Luxembourg: Publications Office of the European Union, 2019. 20 p. ISBN 978-92-9497-434-1; 978-92-9497-431-0
By:
  • EMCDDA expert network (Devaux C. as collaborator for DRID network).

Injection of cocaine is associated with a recent HIV outbreak in people who inject drugs in Luxembourg.

  • HIV Clinical and Translational Research
  • Competence Center for Methodology and Statistics
  • Clinical and Epidemiological Investigation Center
May 16, 2019
2019 May. PLoS One.14(5):e0215570.
By:
  • Arendt V
  • Guillorit L
  • Origer A
  • Sauvageot N
  • Vaillant M
  • Fischer A
  • Goedertz H
  • Francois JH
  • Alexiev I
  • Staub T
  • Seguin-Devaux C.

Multicenter evaluation of the cobas(R) HIV-1 quantitative nucleic acid test for use on the cobas(R) 4800 system for the quantification of HIV-1 plasma viral load.

  • HIV Clinical and Translational Research
May 01, 2019
2019 May. J Clin Virol.114:43-49.
By:
  • Adams P
  • Vancutsem E
  • Nicolaizeau C
  • Servais JY
  • Pierard D
  • Francois JH
  • Schneider T
  • Paxinos EE
  • Marins EG
  • Canchola JA
  • Seguin-Devaux C.

Earlier initiation of antiretroviral treatment coincides with an initial control of the HIV-1 Sub-Subtype F1 outbreak among men-having-sex-with-men in Flanders, Belgium.

  • HIV Clinical and Translational Research
March 26, 2019
2019 Mar. Front Microbiol.10:613.
By:
  • Vinken L
  • Fransen K
  • Cuypers L
  • Alexiev I
  • Balotta C
  • Debaisieux L
  • Seguin-Devaux C
  • Garcia Ribas S
  • Gomes P
  • Incardona F
  • Kaiser R
  • Ruelle J
  • Sayan M
  • Paraschiv S
  • Paredes R
  • Peeters M
  • Sonnerborg A
  • Vancutsem E
  • Vandamme AM
  • Van den Wijngaert S
  • Van Ranst M
  • Verhofstede C
  • Stadler T
  • Lemey P
  • Van Laethem K.

In-vitro viral suppressive capacity correlates with immune checkpoint marker expression on peripheral CD8+ T cells in treated HIV-positive patients.

  • HIV Clinical and Translational Research
March 01, 2019
2019 Mar. Aids.33(3):387-398.
By:
  • Pannus P
  • Adams P
  • Willems E
  • Heyndrickx L
  • Florence E
  • Rutsaert S
  • De Spiegelaere W
  • Vandekerckhove L
  • Seguin-Devaux C
  • Vanham G.

Malnutrition, Growth Response and Metabolic Changes Within the First 24 Months After ART Initiation in HIV-infected Children Treated Before the Age of 2 Years in West Africa.

  • HIV Clinical and Translational Research
August 01, 2018
2018 Aug. Pediatr Infect Dis J.37(8):781-787.
By:
  • Jesson J
  • Dahourou DL
  • Amorissani Folquet M
  • Malateste K
  • Yonaba C
  • N'Gbeche MS
  • Ouedraogo S
  • Mea-Assande V
  • Amani-Bosse C
  • Blanche S
  • Timite-Konan M
  • Leroy V
  • Monod Anrs 12206 Study Group (Arendt V DCaSJacftp.

Development of Mimokines, chemokine N terminus-based CXCR4 inhibitors optimized by phage display and rational design.

  • Immuno-Pharmacology and Interactomics
  • HIV Clinical and Translational Research
August 01, 2018
2018 Aug. J Leukoc Biol.104(2):343-357. Epub 2018 Mar 23.
By:
  • Fievez V
  • Szpakowska M
  • Mosbah A
  • Arumugam K
  • Mathu J
  • Counson M
  • Beaupain N
  • Seguin-Devaux C
  • Deroo S
  • Baudy-Floc'h M
  • Chevigne A.

The need for a European hepatitis C programme monitoring resistance to direct-acting antiviral agents in real life to eliminate hepatitis C.

  • HIV Clinical and Translational Research
July 01, 2018
2018 Jul. J Virus Erad.4(3):179-181.
By:
  • Popping S
  • Cento V
  • Garcia F
  • Ceccherini-Silberstein F
  • Seguin-Devaux C
  • Vijver DA
  • Boucher CA
  • on behalf of the HEPVIR working group of the European Society for translational Antiviral Research (ESAR).